The costs and consequences of three policy options for reducing heroin dependency

Drug and Alcohol Review

Volumn 26, Issue 4, 2007, Pages 369-378

  Moore, Timothy J ^a   Ritter, Alison ^a,b,d   Caulkins, Jonathan P ^c  

^a TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Cost consequences; Cost effectiveness; Drug policy; Heroin dependency; Methadone maintenance

Indexed keywords

METHADONE;

ARTICLE; AUSTRALIA; COST BENEFIT ANALYSIS; DRUG CONTROL; DRUG DEPENDENCE TREATMENT; ECONOMICS; EVALUATION; HEALTH CARE POLICY; HEROIN DEPENDENCE; HUMAN; LAW ENFORCEMENT; LEGAL ASPECT; METHODOLOGY; PATIENT COMPLIANCE; PRISON; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; RESIDENTIAL CARE; TREATMENT OUTCOME; UTILIZATION REVIEW;

AUSTRALIA; COST-BENEFIT ANALYSIS; DRUG AND NARCOTIC CONTROL; HEALTH POLICY; HEROIN DEPENDENCE; HUMANS; LAW ENFORCEMENT; METHADONE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PRISONS; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; RESIDENTIAL TREATMENT; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 34250368731     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701373883     Document Type: Article

References (33)

1. Rydell CP, Everingham SS. Controlling cocaine: supply versus demand programs. Santa Monica, CA: RAND Corporation, 1994.
2. Crane BD, Rivolo AR, Comfort GC. An empirical examination of counterdrug interdiction program effectiveness, Alexandria, VA: Institute for Defense Analysis, 1997.
3. Manski CF, Pepper JV, Petrie CV. Assessment of two cost-effectiveness studies on cocaine control policy. Washington, DC: National Academy Press, 1999.
4. Caulkins JP, Chiesa J, Everingham SS. Response to the National Research Council's Assessment of RAND's Controlling Cocaine Study, MR-1265. Santa Monica, CA: RAND Corporation, 2000.
5. Tragler G, Caulkins JP, Feichtinger G. Optimal dynamic allocation of treatment and enforcement in illicit drug control. Op Res 2001;49:352-62.
6. Schulte C, Mouzos J, Makkai T. Drug use monitoring in Australia: 2004 annual report on drug use among police detainees. AIC Research and Public Policy Series no. 65. Canberra: Australian Institute of Criminology, 2005.
7. McCollister KE, French MT, Inciardi JA, Butzin CA, Martin SS, Hooper RM. Post-release substance abuse treatment for criminal offenders: a cost-effectiveness analysis. J Quant Grim 2003;19:389-407.
8. Hawken A. The economics of alternative sentencing: assessing the substance abuse and crime prevention act. Doctoral dissertation. RAND Graduate School, Santa Monica, CA: RAND, 2006.
9. Shanahan M, Lancsar E, Haas M, Lind B, Weatherburn D, Chen S. Cost-effectiveness analysis of the New South Wales adult drug court program. Eval Rev 2004;28: 3-27.
10. Warren E, Viney R, Shearer J, Shanahan M, Wodak A, Dolan K. Value for money in drug treatment: economic evaluation of prison methadone. Drug Alcohol Depend 2006 [Epub ahead of print: available online 17 Feb 2006].
11. Mauskopf JA, Paul JE, Grant DM, Stergachis A. The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics 1998;13:277-88.
12. McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of cost-benefit analysis in healthcare: matching the art to the science. Pharmacoeconomics 1999; 15:357-67.
13. Sindelar JL, Jofre-Bonet M, French MT, McLellan AT. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug Alcohol Depend 2004;73:41-50.
14. Ross J, Teesson M, Darke S. Twelve month outcomes of treatment for heroin dependence: findings form the Australian Treatment Outcome Study (ATOS), Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2003.
15. Holt T, Ritter A, Pahoki S, O'Keeffe B, Thomson N, Swan A. Australian Treatment Outcome Study: heroin, 12-month outcomes report: Victoria. Melbourne: Turning Point Alcohol and Drug Centre, 2004.
16. Shanahan M, Havard A, Mills K, et al. Health services use and treatment costs over 12 months among heroin users: findings from the Australian Treatment Outcome Study (ATOS), Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2003.
17. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1997.
18. Steering Committee for the Review of Government Service Provision (SCRGSP). Report on government services 2003. Canberra: Productivity Commission, 2004.
19. KPMG Consulting. Review of the Victorian prisons drug strategy. Melbourne: Victorian Department of Justice, 1999.
20. Black E, Dolan K, Wodak A. Supply, demand and harm reduction strategies in Australian prisons: implementation, cost and evaluation. ANCD Research Paper no. 9. Canberra: ANCD, 2004.
21. Inciardi J, Martin S, Butzin C, Hooper R, Harrison L. An effective model of prison-based treatment for drug-involved offenders. J Drug Issues 1997;27:261-78.
22. Martin SS, Butzin CA, Inciardi JA. Assessment of a multistage therapeutic community for drug-involved offenders. J Psychoact Drugs 1995;27:109-16.
23. Simpson DD, Joe GW. A longitudinal evaluation of treatment engagement and recovery stages. J Subst Abuse Treat 2004;27:89-97.
24. Gossop M, Marsden J, Stewart D, Rolfe A. Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend 2000;60:275-86.
25. Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend 2001;62:255-64.
26. Gossop M, Marsden J, Stewart D, Kidd T. The National Treatment Outcome Research Study (NTORS): 4-5-year follow-up results. Addiction 2003;98:291-303.
27. Darke S, Kaye S, Ross J. Transitions between the injection of heroin and amphetamines. Addiction 1999;94: 1795-803.
28. Lind B, Weatherburn D, Chen S. New South Wales Drug Court evaluation: cost-effectiveness. Sydney: NSW Bureau of Statistics and Research, 2002.
29. Degenhardt L, Conroy E, Gilmour S, Collins L. The effect of a reduction in heroin supply in Australia upon drug distribution and acquisitive crime. BMJ 2005;45:2-24.
30. Dietze P, Fitzgerald J. Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles? Drug Alcohol Rev 2002;21:295-303.
31. Weatherburn D, Jones C, Freeman K, Makkai T. Supply control and harm reduction: lessons from the Australian heroin 'drought'. Addiction 2003;98:83-91.
32. NEPOD Research Group. National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): report of results and recommendations. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2001.
33. Clark N, Gospodarevskaya E, Harris A, Ritter A. Estimating the cost of heroin use in Victoria, final report. Melbourne: Premier's Drug Prevention Council, 2003.